Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
6
55%
Ph phase_2
1
9%
Ph phase_3
1
9%
Ph phase_4
2
18%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Other(1)

Detailed Status

Completed10
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A6 (54.5%)

Trials by Status

completed1091%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11